AlgiSys BioSciences, Inc.
PrivateLast Round
Accelerator
May 21, 2025
Total Funding Raised
$2.58M
Company Overview
AlgiSys BioSciences, Inc. operates in Healthcare & Life Sciences and is based in Cleveland, Ohio. Its latest recorded funding round was an Accelerator round in May 2025.
AlgiSys BioSciences, Inc. is a biotechnology company that produces EPA-rich omega-3 nutritional oils and plant-based protein from microalgae using a proprietary fermentation process.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AlgiSys BioSciences, Inc. Comparables
Compare AlgiSys BioSciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Demeter Bio-Tech (Zhuhai) Co., Ltd. | 79% | |
| Mara Renewables Corporation | 78% | |
| Phytolipid Technologies | 76% |
For institutional investors. Book with your work email.
AlgiSys BioSciences, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | May 21, 2025 | ||||
| Early Funding | Apr 4, 2025 | ||||
| Series B | Nov 4, 2021 | ||||
| Series A | Jan 18, 2012 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AlgiSys BioSciences, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hatch Blue | Accelerator |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 22, 2026
Monthly visitors increased 163% MoM.
- Nov 11, 2025
Monthly visitors increased 44% MoM.
For institutional investors. Book with your work email.
AlgiSys BioSciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AlgiSys BioSciences, Inc.'s valuation, stock price, and market status.
Is AlgiSys BioSciences, Inc. a public or private company?
AlgiSys BioSciences, Inc. is a private company.
What is the current stock price of AlgiSys BioSciences, Inc.?
AlgiSys BioSciences, Inc. is a private company, so its shares have no public market price. Caplight tracks AlgiSys BioSciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AlgiSys BioSciences, Inc. worth (valuation)?
Valuation information for AlgiSys BioSciences, Inc. is not publicly available.
Can I buy AlgiSys BioSciences, Inc. stock?
AlgiSys BioSciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AlgiSys BioSciences, Inc.'s last funding round?
AlgiSys BioSciences, Inc.'s most recent funding round was Accelerator on May 21, 2025.
Who are the main investors in AlgiSys BioSciences, Inc.?
Key investors in AlgiSys BioSciences, Inc. include Hatch Blue, National Science Foundation.
Will AlgiSys BioSciences, Inc. IPO soon?
No public IPO plans have been announced for AlgiSys BioSciences, Inc..
How can I track AlgiSys BioSciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in AlgiSys BioSciences, Inc.'s shares on secondary markets.